The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Thromboembolism (TE) in patients (pts) with bladder cancer treated with checkpoint inhibitors (CPIs).
 
Iris Yeong- Fung Sheng
No Relationships to Disclose
 
Shilpa Gupta
Stock and Other Ownership Interests - Nektar
Honoraria - AstraZeneca; Bristol-Myers Squibb; Exelixis; Janssen Oncology; Merck Sharp & Dohme; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Janssen Oncology
Research Funding - Astellas Medivation (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst)
 
Chandana A. Reddy
No Relationships to Disclose
 
Dana E Angelini
No Relationships to Disclose
 
Pauline Funchain
Consulting or Advisory Role - Eisai
 
Tamara A. Sussman
No Relationships to Disclose
 
Joseph Sleiman
No Relationships to Disclose
 
Timothy D. Gilligan
Travel, Accommodations, Expenses - Dendreon
 
Moshe Chaim Ornstein
Consulting or Advisory Role - Eisai; Exelixis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis
 
Alok A. Khorana
Honoraria - AngioDynamics; Bayer; Halozyme; Janssen; Pfizer; Pharmacyte Biotech
Consulting or Advisory Role - Bayer; Halozyme; Janssen; Pfizer; Pharmacyclics; Pharmacyte Biotech; Seagen
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Leap Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen; Janssen; Pfizer